Back to search

Article

Molecular Pathology Testing for Non-small Cell Lung Cancer: An Observational Study of Elements Currently Present in Request Forms and Result Reports and The Opinion of Different Stakeholders

2021-04-09

Abstract excerpt

<h4>Background: </h4> For patients with non-small cell lung cancer (NSCLC), targeted therapies are becoming part of the standard treatment. It is of question which information the clinicians provide on test requests and how the laboratories adapt test conclusions to this knowledge and regulations. <h4>Methods: </h4> This study consisted of two components; 1) checking the presence of pre-defined elements (administr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2c544507-8c0f-5217-9596-0378fcac8c6d
DOI
10.21203/rs.3.rs-149142/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular Pathology Testing for Non-small Cell Lung Cancer: An Observational Study of Elements Currently Present in Request Forms and Result Reports and The Opinion of Different StakeholdersDOI 10.21203/rs.3.rs-149142/v1
Quality Assessment of Reporting Performance for EGFR Molecular Diagnosis in Non-Small Cell Lung Cancer.Semantic proximity
Barries in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World-Evidence ScenarioSemantic proximity
Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung.Semantic proximity
Expert opinion on NSCLC small specimen biomarker testing - Part 2: Analysis, reporting, and quality assessment.Semantic proximity
[Mutational oncology of lung cancer: molecular markers, drugs, negotiation conditions and experiences in national reference centers.]Semantic proximity
Lung cancer biomarker testing: perspective from EuropeSemantic proximity
Physician preferences of biomarker testing strategies in newly diagnosed stage IV non-small cell lung cancer patients.Semantic proximity
A Case-control Study Supporting the Use of Liquid Biopsy in the Targeted Therapy for Lung CancerSemantic proximity
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe.Semantic proximity
Biomarker Testing for Actionable Alterations in NSCLC-Perspectives from US-Based Academic and Community Oncologists: A Podcast.Semantic proximity
Molecular profiling of advanced non-small cell lung cancer in the era of immunotherapy approach: a multicenter Italian observational prospective study of biomarker screening in daily clinical practice.Semantic proximity
Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non–Small-Cell Lung Cancer With Rare or Complex Mutational ProfilesSemantic proximity
Select a neighboring publication to make it the new centre.